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Mycolate-containing compounds constitute major
strategic elements of the protective coat surrounding
the tubercle bacillus. We have previously shown that
FAAL32-Pks13 polyketide synthase catalyzes the
condensation reaction, which produces a-alkyl
b-ketoacids, direct precursors of mycolic acids. In
contrast to the current biosynthesis model, we
show here that Pks13 catalyzes itself the release of
the neosynthesized products and demonstrate that
this function is carried by its thioesterase-like
domain. Most importantly, in agreement with the
prediction of a trehalose-binding pocket in its cata-
lytic site, this domain exhibits an acyltransferase
activity and transfers Pks13’s products onto an
acceptor molecule, mainly trehalose, leading to the
formation of the trehalose monomycolate precursor.
Thus, this work allows elucidation of the hinge step of
the mycolate-containing compound biosynthesis
pathway. Above all, it highlights a unique mechanism
of transfer of polyketide synthase products in myco-
bacteria, which is distinct from the conventional
intervention of the discrete polyketide-associated
protein (Pap)-type acyltransferases.
INTRODUCTION
Tuberculosis (TB) represents a major public health problem
worldwide. This disease remains today one of the leading causes
of death from an infectious agent. Nearly ninemillion people fell ill
and 1.3million died from TB in 2012 (WHO, 2013). Drug-sensitive
TB can be cured with a standard 6-month therapy. However, the
emergence of multidrug-resistant and extensively drug-resistant
Mycobacterium tuberculosis strains has challenged TB control.
Therefore, the discovery of novel pharmacological targets for
the development of a new generation of drugs is urgently
needed.1660 Chemistry & Biology 21, 1660–1669, December 18, 2014 ª2014The very thick envelope of Mycobacterium tuberculosis and
other pathogenicmycobacteria is characterized by a broad array
of exotic complex lipids that are key players in the infectious pro-
cess (Daffe´ et al., 2014; Jackson et al., 2007). Mycolic acids are
a-branched and b-hydroxylated fatty acids of exceptional chain
length (e.g., C60-C90 inMycobacterium, C22-C36 inCorynebacte-
rium) that typify the Corynebacteriales order (Marrakchi et al.,
2014). They constitute the major components of the outer mem-
brane (mycomembrane) and are therefore determining factors in
the permeability of the envelope (Gebhardt et al., 2007). The vast
majority of themycolic acids esterify the pentaarabinosyl ends of
the arabinogalactan forming the cell wall mycolyl-arabinogalac-
tan-peptidoglycan (mAGP) complex. The latter would bind to the
human natural killer (NK) cell natural cytotoxicity receptor
NKp44, playing a potential role in maintaining NK cell activation
(Esin et al., 2013). The remaining mycolic acids form the myco-
late-containing lipids composed of one or two mycolyl chains
linked to the 6 and 60 positions of trehalose and more scarcely
to glucose or glycerol. These lipids constitute major determi-
nants of the pathologies caused by the mycobacteria, acting
either as proinflammatory agents, like trehalose dimycolate
(TDM) and trehalose monomycolate (TMM) (Geisel et al., 2005;
Glickman, 2008), or as T cell activators via their presentation
by CD1b protein, like glucose monomycolate (GMM) and
glycerol monomycolate (GroMM) (Layre et al., 2009; Moody
et al., 2002).
Given the significance of the mycolate-containing compounds
in the dialog between the tubercle bacillus and the infected host,
the identification of the different biosynthesis steps leading to
their formation is a very important issue, especially for the search
of novel TBdrug targets. Their biosynthesispathway endsupwith
the transfer of the mycoloyl chains from TMM onto a polyol core
(arabinogalactan, trehalose, glucose, and possibly glycerol) by
the Ag85ABC mycoloyl transferase complex (Belisle et al.,
1997; Jackson et al., 1999). Beforehand, the mycoloyl chains
are produced by a mixed fatty acid synthase (FAS)-polyketide
synthase (PKS) biosynthesis pathway,whosepivotal step is cata-
lyzed by the FAAL32-Pks13 system (Gavalda et al., 2009; Le´ger
et al., 2009). The discrete fatty acyl-AMP ligase FAAL32 (or
FadD32) activates very long (C16-C60) fatty acyl chains, the ‘‘mer-
omycolyl chains,’’ into AMP derivatives and loads them ontoElsevier Ltd All rights reserved
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uses exceptionally long (C16-C26) extender units it condenses to
the meromycolyl chains, forming a-alkyl b-ketoesters, the direct
precursors of mycolic acids (see Figure S1 available online). We
have deciphered the different reaction steps catalyzed by
Pks13 (Gavalda et al., 2009; Le´ger et al., 2009). However, the
mechanism of release of its products as well as the subsequent
steps leading to the formation of TMM remain unknown. The
acyl carrier protein (ACP) domains of the PKSs are activated by
a phosphopantetheinyl (P-pant) arm that carries the growing
acyl chains (e.g., Figure S1) (Walsh et al., 1997). Upon reaching
its full length, thepolyketide isgenerally released fromtheenzyme
by the action of a thioesterase (TE) domain found at the C termi-
nus, typically via an hydrolysis mechanism (in the case of linear
molecules) or via a macrocyclisation (Hertweck, 2009). Given
the high hydrophobicity of Pks13’s products, the current model
proposes that they would not be released as free acids in the
bacteriumbyPks13’sownputativeTE (TEPks13) domainbut trans-
ferred via a discrete unknown acyltransferase (a mycoloyl trans-
ferase) onto a hydrophilic acceptor unit (Takayama et al., 2005)
(Figure S1). Thus, the TEPks13 domain might have a distinct role,
like the function of ‘‘proofreading’’ generally accomplished by
an external type II thioesterase (Koglin and Walsh, 2009).
The present work investigates the process of release of
mycolic acid precursors from Pks13 enzyme and reveals a
mechanism of transfer of PKS products during the formation of
complex lipids in mycobacteria. Thus, it allows elucidation of
long-sought missing pieces of the mycolate-containing com-
pound biosynthesis pathway.
RESULTS
Pks13 Generates Polyol Derivatives
To characterize the step of release of mycolic acid precursors
from Pks13, we had to perform in vitro experiments using the pu-
rified enzyme. Indeed, besides the fact that Pks13 is essential for
the mycobacterial survival (Portevin et al., 2004), the blockage of
one step within mycolic acid biosynthesis has proven to inacti-
vate the complete biosynthesis pathway in the past (Vilche`ze
et al., 2000). For solubility and availability reasons, the conden-
sation assays were run in the presence of the substrates natu-
rally used by Corynebacterium Pks13, a radiolabeled myristic
acid ([1-14C]C14 acid) and a chemically synthesized C16 car-
boxy-acyl-CoA (carboxy-C16-CoA), rather than the longer sub-
strates found in Mycobacterium. The mycobacterial Pks13
enzyme was shown to be able to use these short substrates in
a recombinant Corynebacterium strain to synthesize mycolic
acids in vivo (Gavalda et al., 2009). Published data have sug-
gested that a,a-D-trehalose or D-glucose play a role in the
biosynthesis of mycolic acids (Prome´ et al., 1974; Puzo et al.,
1979; Shimakata et al., 1986), and a more recent report has
shown the requirement of trehalose (Tropis et al., 2005). In order
to seek for their potential involvement during the condensation
reaction catalyzed by Pks13, assays supplemented with these
sugars were realized. The intact reaction media were analyzed
by thin-layer chromatography (TLC). We observed the glucose-
(Figure 1A, spot c) or trehalose-dependent (Figure 1A, spots a
and b) production of radiolabeled compounds, which migrated
close to the natural GMM, TMM, and TDM standards, respec-Chemistry & Biology 21, 1660–166tively. The MALDI-TOF mass spectrometry (MS) analysis of the
cold condensation products was very challenging because of
the very low quantity of material. Spectra of the compounds ob-
tained in the presence of trehalose and glucose specifically dis-
played ion peaks expected for the mono-a-alkyl b-ketoacyl
trehalose (TMM keto form or ‘‘TMMk’’) and the mono-a-alkyl
b-ketoacyl glucose (GMM keto form or ‘‘GMMk’’), respectively
(Figure 1B). MALDI-TOF/TOFMS/MS analyses induced the frag-
mentation of these molecules and confirmed their identification
(Figure S2).
Interestingly, we observed that an additional radiolabeled
compound was formed when glycerol was added to the stocks
of enzymes used in the condensation assays (Figure 1A, spot
d). MALDI-TOF MS analysis revealed the presence of a-alkyl
b-ketoacyl glycerol (GroMM keto form or ‘‘GroMMk’’; Figure 1B).
Moreover, in the absence of acceptor molecule in the reaction,
the labeling of the most apolar compound increased (Figure 1A,
spot e). The purified compound exhibited a behavior similar to
that of the long-chain ketone standard during TLC (Figure S3A)
and was identified as a C29 long-chain ketone by MALDI-TOF
MS with a [M+H]+ ion peak at m/z 423.35 (expected m/z value:
423.46). Such a compound resulted from the spontaneous
decarboxylation of free a-alkyl b-ketoacid released from Pks13
by hydrolysis (Figure S3B).
These data altogether demonstrated that Pks13 generates
saccharidic derivatives corresponding to trehalosemono-a-alkyl
b-ketoester, the direct precursor of TMM, and to glucose mono-
a-alkyl b-ketoester but also a nonsaccharidic derivative, namely
glycerol mono-a-alkyl b-ketoester. The quantitative variation of
condensation products was measured with respect to the initial
concentration of acceptor molecule in the reaction. Significant
amounts of TMMkwere already observed at the lowest trehalose
concentrations: 0.07 and 0.7 mM (Figure S4). In a general
manner, increasing concentrations of a given acceptor led to a
gradual increase of the quantity of the corresponding a-alkyl
b-ketoacid derivative formed up to a plateau. In parallel, the la-
beling of the long-chain ketone deriving from the free a-alkyl
b-ketoacid decreased (Figure S4). Thus, the concentration of
acceptor unit available in the reaction medium determines the
proportions of a-alkyl b-ketoester and a-alkyl b-ketoacid
produced by Pks13. To define the preference of the enzyme be-
tween the three acceptors, competition experiments were real-
ized. Different pairs of acceptors at equimolar concentrations
were mixed in the reaction medium prior to the addition of
FAAL32 and Pks13. Data showed that the predilection of
Pks13 for the acceptor unit is the following: trehalose, glucose,
and glycerol, in decreasing order (Figure 1C).
Pks13 Has a Narrow Acceptor Specificity
In order to establish the nature of the structural determinants that
play a role in the recognition by Pks13, a series of natural analogs
of glucose and trehalose (Figure 2B) was evaluated as putative
acceptors of the condensation products. In the presence of 6-
deoxy-D-glucose, which is devoid of hydroxyl group at position
6where the acylation naturally occurs, no derivative could be de-
tected by TLC (Figure 2A). D-mannose and D-allose, the epimers
at positions 2 and 3 of glucose, respectively, could serve as ac-
ceptors in vitro (Figure 2A, spots c0 0 and c0 0 0), although with a
lower efficiency than D-glucose (spot c) and, unexpectedly,9, December 18, 2014 ª2014 Elsevier Ltd All rights reserved 1661
Figure 1. Formation of Different Types of a-alkyl b-ketoacid Derivative by Pks13
(A) TLC/phosphorimaging analysis of condensation assays performed in the absence () or in the presence (+) of 50 mM of each putative acceptor. Repre-
sentative data of three independent experiments. Stand, standard mix of TMM, TDM, and GMM (from C. glutamicum) revealed by anthrone spraying. Eluent:
CHCl3/CH3OH/H2O, 65/25/4. Spots: a, TMMk; b, palmitoyl TMMk (see note below); c, GMMk (see note in Figure 2 legend); d, GroMMk; e, long-chain ketone
(LCK). AKA: a-alkyl b-ketoacid. Note that spot b was identified as (a-myristyl b-ketopalmitoyl),palmitoyl trehalose by MALDI-TOF MS (monosodium adduct at
m/z: 1051.75; theoreticalm/z value: 1051.76); the C16 chain might come from the degradation of an a-alkyl b-ketoacyl chain linked to trehalose by intramolecular
retro-Claisen reaction as described previously (Puzo et al., 1979). The minor radiolabeled spots are not linked to the condensation activity.
(B) MALDI-TOFMS analysis of condensation products obtained in the presence of different acceptor molecules. The assays were performed using cold carboxy-
C16-CoA, C14 acid and 100 mM acceptor molecule. The formation of C32 compounds, resulting from the condensation of C16 acid and carboxy-C16-CoA, is most
likely due to the fortuitous generation of C16 acid from carboxy-C16-CoA during the assays. Theoreticalm/z values (calculated with the Data Explorer program) of
monosodium adducts: C30 TMMk, 813.53; C32 TMMk, 841.56; C30 GMMk, 651.48; C32 GMMk, 679.51; C30 GroMMk, 563.46; C32 GroMMk, 591.50.
(C) Competition experiments between trehalose, glucose, and glycerol as acceptor molecules. The biosynthesis yield of each type of a-alkyl b-ketoacid de-
rivative, in the presence of one or two acceptor molecules at equimolar concentrations, was measured by TLC/phosphorimaging analysis. Data are means of
three independent experiments ± average deviations; they are expressed as relative labelings with the points at 100 mM trehalose arbitrarily set to 100%.
See also Figures S2–S4.
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Figure 2. Analogs of Glucose and Trehalose as Putative Acceptors of Pks13’s Products
(A) TLC/phosphorimaging analysis of condensation assays performed in the absence () or in the presence (+) of 100 mM of putative acceptor. Representative
data of three independent experiments. Stand, standard [1-14C]C14 acid. Eluent: CHCl3/CH3OH/H2O, 65/25/4. Spots: a–d and f, mono-a-alkyl b-ketoester of the
tested polyol; e, long-chain ketone (LCK); AKA, a-alkyl b-ketoacid. Note that the glucose/galactose/allose a-alkyl b-ketoesters appeared as double spots (c, c0,
and c0 0 0, respectively) most likely because, once released in solution, the neosynthesized a-alkyl b-ketoacyl a-D-monosaccharides isomerize partially into the b
tautomers. Indeed, the major forms of the corresponding free sugars in solution are the b-D-glycopyranose tautomers, whereas the mannose, whose a
conformation is the major form, generated a single apparent spot (c0 0) of a-alkyl b-ketoester.
(B) Structure of tested compounds.
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tion constraint, which allows it to topologically superimpose on
half of a glucosemolecule (Figure 2B) andmay explain its relative
success as an acceptor. In contrast, D-galactose, the epimer at
position 4 of glucose, was a very bad acceptor (Figure 2A, spot
c0). These data suggested that the topology of the hydroxyl
group at position 4 might dramatically influence the acylation
of the hydroxyl group at position 6, probably by steric effect (Fig-
ure 2B). In the presence of D-arabinose, the pentose unit found
at the extremities of the cell wall arabinogalactan and carrying
most of the mycoloyl chains in the outer membrane, a very
weak signal was observed (Figure 2A, spot f). In the case of di-
saccharides, the yield of derivative biosynthesis wasmuch lower
with D-maltose [Glc(a 1/4)Glc] (Figure 2A, spot a0) than with
trehalose [Glc(a,a 1/1)Glc] (spot a), underlining the importance
of the nature of the glycosidic bond (Figure 2B). The signal ob-
tained from D-cellobiose [Glc(b 1/4)Glc] (Figure 2A, spot a0 0)
was even weaker than that observed with maltose, showing
that a a anomery for the nonreducing glucose unit was favorable
to the acyl transfer.
In conclusion, the FAAL32-Pks13 system has a narrow
acceptor specificity: both the a-D-glucosyl motif and the
(1/1) link between two glucose units compose the structural
bases of an efficient transfer of the neosynthesized a-alkyl
b-ketoacyl chains.
Prediction of a Trehalose-Binding Pocket in the TEPks13
Domain
We showed above that the FAAL32-Pks13 system itself cata-
lyzes the release of its products. The fatty acyl-AMP ligase
FAAL32 and the acyltransferase domain of Pks13 possess an
acyltransferase activity, but they are dedicated to loading the
acyl chain of both substrates onto Pks13 (Figure S1) (Gavalda
et al., 2009; Le´ger et al., 2009). We hypothesized that the puta-
tive TE domain of Pks13 was responsible for the release step.
The TEPks13 domain matched with a/b hydrolases of theChemistry & Biology 21, 1660–166esterase-lipase superfamily, which cleave carboxylic (thio)ester
bonds via a nucleophilic attack on the carbonyl. Structure-based
sequence comparison of members of this family and programs
for model quality evaluation validated the structure of the TE
domain of the human fatty acid synthase (TEhFAS) as the best
template for homology modeling as well as the good quality of
the resulting model (see Supplemental Experimental Proce-
dures). The latter was performed using the structure of TEhFAS
in complex with a polyunsaturated fatty acyl substrate analog
(Protein Data Bank [PDB] ID 3TJM) (Zhang et al., 2011). The
FAS catalyzes the biosynthesis of fatty acids via a Claisen
condensation mechanism, a function closely related to that of
Pks13. The TEPks13 model displayed a strict conservation of
the catalytic triad (Ser1533, Asp1560, His1699 in the TEPks13
domain) (Figure 3A) and of the carboxyl(thio)esterase consensus
sequence ‘‘G-X-S-X-G’’ holding the catalytic serine residue
(Ser1533) responsible for the nucleophilic attack and the forma-
tion of a transient covalent link with the biosynthesis product.
Furthermore, superimposition of the TEPks13 model with the
TEhFAS structure revealed that the long groove-tunnel that ac-
commodates the fatty acyl chain in TEhFAS domain (Zhang
et al., 2011) was also present in TEPks13 model. Interestingly, un-
like TEhFAS, the TEPks13 predicted tunnel would open onto a large
groove communicating with other grooves and tunnels and
might potentially fit a very long fatty acyl chain (Figure S5). En-
zymes of the Ag85ABC complex also belong to the a/b hydrolase
family and catalyze the transfer of a mycoloyl chain onto a polyol
core (the trehalose monomycolate), a function closely related to
the mechanism of release of Pks13 products. To seek a putative
trehalose-binding site in the TEPks13 domain, the model was
comparedwith the crystal structure of Ag85B-trehalose complex
(PDB ID 1F0P) (Anderson et al., 2001). Strikingly, the trehalose-
binding pocket near the catalytic site in Ag85B (Figure 3C) super-
imposedwell with a pocket at the bottom of the catalytic cavity in
the TEPks13 domain, whichmight nicely accommodate the disac-
charide (Figure 3B). In particular, two residues of Ag85B, the9, December 18, 2014 ª2014 Elsevier Ltd All rights reserved 1663
Figure 3. Homology Model of TEPks13 Domain and Its Predicted Trehalose-Binding Pocket
(A) Semi-transparent surface representation of the overall structure with the embedded backbone trace in yellow. The polyunsaturated ligand of the
TEhFAS domain, methyl g-linolenylfluorophosphonate, was positioned by superimposition of the model with the TEhFAS complex structure (PDB ID
3TJM) (Zhang et al., 2011) and drawn as orange sticks. The trehalose ligand of Ag85B enzyme was positioned by superimposition of the model with
the Ag85B-trehalose complex structure (PDB ID 1F0P) (Anderson et al., 2001) and colored with carbon atoms in green. Residues of the catalytic triad,
Ser1533, Asp1560, and His1699, as well as side chains of additional residues potentially interacting with trehalose (Lys1588 and Glu1698) are colored
in cyan. Additional interactions might be mediated via water molecules and protein main chain atoms, as in the Ag85B-trehalose complex (Anderson
et al., 2001). N, O, and P atoms are in blue, red, and purple, respectively.
(B) Surface representation of the predicted trehalose-binding pocket in the TEPks13 domain. Residues potentially interacting with trehalose are colored in cyan.
(C) Surface representation of the trehalose-binding pocket in the structure of the Ag85B-trehalose complex. Residues whose side chain directly interacts with
trehalose are colored in cyan.
See also Figure S5.
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lose via their side chain, were conserved in the TEPks13 model
(Ser1533 and Lys1588, respectively). The side chains of two
additional residues of the TEPks13 domain, Glu1698 and the cat-
alytic His1699, might also stabilize a trehalose ligand (Figures 3A
and 3B). The hydroxyl group at position 6 of trehalose, where the
acylation naturally occurs, would point toward the head group of
the fatty acyl ligand, at an adequate distance for a transacylation
reaction (Figure 3A).
Taken altogether, these data suggested that the TEPks13
domain was potentially active as a carboxyl(thio)esterase but
that it might also be able to welcome a polyol-type molecule in
its active site at a proper position for the transfer of an a-alkyl
b-ketoacyl chain.
The Isolated TEPks13 Domain Exhibits
an Acyltransferase Activity
To experimentally determine the function of TEPks13 domain, we
designed an activity assay in the presence of the isolated domain1664 Chemistry & Biology 21, 1660–1669, December 18, 2014 ª2014and of a model substrate, palmitoyl-CoA (C16-CoA), which holds
a thioester bond between its acyl chain and the P-pant arm of the
CoA moiety. We first validated the assay using the whole Pks13
in the presence of [1-14C]C16-CoA. The release of free C16 acid
was strictly dependent upon the presence of Pks13 (Figure 4A,
lane 3). In the presence of polyol, additional radiolabeled com-
pounds appeared suggesting the formation of palmitoyl glucose
(spot c), trehalose (spots a and b), and glycerol (spot d) deriva-
tives (Figure 4A, lanes 4–7). Importantly, the synthesis of palmitic
acid or polyol derivatives could not be detected using heat-inac-
tivated Pks13 (Figure 4A, lane 2). Then, the TEPks13 domain was
produced and purified to homogeneity from a recombinant
E. coli strain (Figure S6). Similar to Pks13, incubation of the sepa-
rate TE domain in the presence of [1-14C]C16-CoA induced the
release of some C16 acid as shown by TLC andMS analysis (Fig-
ure 4B, lanes 4 and 7–10; Table S1). It also triggered the forma-
tion of additional compounds in the presence of molecules
holding an a-D-glucose unit, namely trehalose, glucose, and
maltose, as well as in the presence of glycerol (Figure 4B, lanesElsevier Ltd All rights reserved
Figure 4. Thioesterase and Acyltransferase
Activities of TEPks13 Domain
These activities were measured in the presence of
a model substrate, [1-14C]C16-CoA, by TLC/
phosphorimaging analysis. Representative data of
three independent experiments. Eluent: Butan-1-
ol/acetic acid/H2O, 80/25/40. Spots: a, monop-
almitoyl trehalose (C16-Tre); a
0, palmitoyl maltose;
a0 0, palmitoyl cellobiose; b, dipalmitoyl trehalose
(diC16-Tre); c, palmitoyl glucose (C16-Glc); c
0,
palmitoyl galactose; c0 0, palmitoyl mannose; d,
palmitoyl glycerol (C16-Gro); d
0, dipalmitoyl glyc-
erol (diC16-Gro).
(A) Validation of the assay using the entire Pks13.
Lane 1, [1-14C]C16-CoA standard; lanes 2–7, as-
says in the absence () or in the presence (+) of the
mentioned putative acceptor molecule (at the
indicated concentration); q, heat-inactivated
Pks13; lane 8, [1-14C]C16 acid standard.
(B) TEPks13 domain activity assays. Lane 1, diC16-Tre standard; lane 2, [1-
14C]C16 acid standard; lane 3, [1-
14C]C16-CoA standard; lanes 4–14, assays in the
absence () or in the presence (+) of the mentioned putative acceptor molecule (at 100 mM); lane 15, mix of C16-Glc and C16-Gro standards; 6dGlc, 6-deoxy-
glucose. Cold standards were visualized by rhodamine B spraying and UV light.
See also Figure S6 and Table S1.
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signals expected for the palmitoylated derivatives of these poly-
ols (Table S1). In the presence of the other tested molecules
(galactose, mannose, 6-deoxy-glucose, arabinose, and cello-
biose), the activity of C16 acyl transfer was very weak or unde-
tectable (Figure 4B). Kinetic experiments performed with the
TEPks13 domain determined an apparent Km for trehalose of
5.5 ± 0.1 mM, which was similar to values reported for treha-
lose-metabolizing enzymes (Kizawa et al., 1995; Riby and Gal-
and, 1985). Consistent with Pks13’s substrate specificity, the
TEPks13 domain exhibited a marked predilection for trehalose
as compared with glucose, with an apparent Km of 518 ±
30mM for the latter. The very high Km value for glucose suggests
that trehalose would be the specific acceptor of the neosynthe-
sized a-alkyl b-ketoacyl chains in vivo.
In conclusion, the isolated TE domain of Pks13 is active and is
able, like the entire Pks13 enzyme, to catalyze the transfer of a
C16 acyl chain from a P-pant arm onto trehalose.
The Transfer of Pks13 Condensation Products
Is Catalyzed by Its Own TE Domain
To demonstrate the involvement of the TE domain in the transfer
of the neosynthesized a-alkyl b-ketoacyl chains onto a polyol
acceptor, the putative catalytic Ser1533 of Pks13 (Figure 3)
was mutated into an Ala residue. Condensation assays for
both wild-type (WT) Pks13 and Pks13 S1533A were performed
in parallel in the presence of both trehalose and glycerol. Anal-
ysis of the intact samples revealed the lack of formation of a-alkyl
b-ketoacid derivatives (TMMk and GroMMk) by Pks13 S1533A
by comparison with WT Pks13 (Figure 5A, lanes 2 and 3). The
lipid moiety of the condensation products was analyzed after
chemical treatment (Figure 5C). A residual synthesis of conden-
sation products (7%) by the mutant enzyme with respect to WT
Pks13 was observed (Figure 5B, lanes 2 and 3). It most likely rep-
resented the a-alkyl b-ketoacyl chain that remained blocked on
the C-terminal ACP domain (Figure S1) in the absence of an
active TE domain.When some of the isolatedWT TEPks13 domainChemistry & Biology 21, 1660–166was added to the condensation assay with Pks13 S1533A, the
acyltransferase function was recovered since some TMMk and
GroMMk were synthesized (Figure 5A, lanes 4 and 5). In this
case, the total condensation rate reached 18%–24% (Figure 5B,
lanes 4 and 5). Thus, theWT TEPks13 domain was able to partially
complement the S1533A mutation in the TE domain of the entire
Pks13 enzyme.
These data altogether established that the TEPks13 domain is
responsible for both the release and the transfer of Pks13 prod-
ucts onto a polyol acceptor molecule, particularly trehalose, and
that S1533 is a key residue for this catalytic process (Figure S7).
In the absence of an active TE domain, there is no catalytic
turnover.
DISCUSSION
It is known that the ultimate biosynthesis steps of the mycolate-
containing compounds are catalyzed by the mycoloyl transfer-
ases of the Ag85 complex. The latter transfers the mycoloyl
chains from the TMMdonor onto an acceptor, mainly arabinoga-
lactan or another TMM but also glucose and possibly glycerol, to
form the mAGP complex, TDM, GMM, and GroMM, which will
reach their final locations in the mycomembrane (Figure 6)
(Belisle et al., 1997; Jackson et al., 1999). However, the steps be-
tween the synthesis of the mycoloyl chains and the formation of
TMM remained unknown, although they have been the subject of
extensive investigations.
The present study allows elucidation of the missing steps and
how to draw a scheme of the mycolate-containing compound
biosynthesis (Figure 6). We have previously reported that after
loading onto Pks13, the meromycolic and carboxyacyl chains
are condensed via a Claisen-type mechanism by the ketosyn-
thase domain of Pks13, resulting in a a-alkyl b-ketoacyl chain
linked to the C-terminal ACP domain (Gavalda et al., 2009).
Here we show that these highly insoluble mycolic acid precur-
sors are not released as free acids in the bacterium by a classical
hydrolysis step but are directly transferred onto a hydrophilic9, December 18, 2014 ª2014 Elsevier Ltd All rights reserved 1665
Figure 5. Condensation Assays Using Pks13
S1533A Enzyme
(A and B) TLC/phosphorimaging analyses. Repre-
sentative data of three independent experiments.
All assays were performed in the presence of
trehalose and glycerol. Lanes 1, control assay
without carboxy-C16-CoA; lanes 2, assay with WT
Pks13; lanes 3, assay with Pks13 S1533A; lanes 4,
assay with Pks13 S1533A plus TEPks13 domain;
lanes 5, similar to lanes 4 with a double concen-
tration of TEPks13 domain (see Experimental Pro-
cedures); stand, cold standard of racemic mixture
of C32 mycolic acid methyl esters (MAME), visual-
ized by rhodamine B spraying and UV light.
(A) Intact reaction media. Eluent: CHCl3/CH3OH/
H2O, 65/25/4.
(B) Lipid moiety of the condensation products.
Eluent: CH2Cl2.
(C) Chemical treatment of the condensation prod-
ucts for analysis of their lipid moiety. R1 = C13, R2 =
C14, X = trehalose or glycerol (in assays 2, 4, and 5
in A and B) or Pks13 S1533A (in assay 3). For de-
tails, see Experimental Procedures.
See also Figure S7.
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rent biosynthesis model, our data demonstrate that their transfer
is not performed by a discrete mycoloyl transferase as proposed
earlier (Besra et al., 1994; Datta and Takayama, 1993; Takayama
et al., 2005) but by Pks13’s own TE domain. Thus, the latter re-
leases the condensation products from the P-pant arm of the
ACP domain, most likely via the formation of a transient ester
bond with its catalytic Ser1533 residue (Figure S7; Figure 6).
Then, the TEPks13 domain catalyzes the cleavage of this bond
and the concomitant transfer of the a-alkyl b-ketoacyl chain
onto trehalose. The previous observations of an accumulation
of a-alkyl b-ketoacyl trehalose in cmrA mycobacterial mutants
deficient in the subsequent mycolic reductase step (Bhatt
et al., 2008; Lea-Smith et al., 2007) are perfectly consistent
with our data. After reduction by CmrA, the resulting TMM is
translocated via MmpL3 transmembrane protein (Grzegorze-
wicz et al., 2012; Tahlan et al., 2012; Varela et al., 2012) toward
the Ag85 complex tightly associated to the mycomembrane
(Bou Raad et al., 2010; Marchand et al., 2012). The Ag85 en-
zymes then use TMM as a substrate for the biosynthesis of the
mAGP complex and the mycolate-containing lipids located in
the mycomembrane (Figure 6). LpqY-SugA-SugB-SugC ABC
transporter mediates the retrograde transport of the extracellular
released trehalose (Kalscheuer et al., 2010). This recycling step
is critical for virulence of M. tuberculosis during the acute infec-
tion phase, which may be linked to the requirement of trehalose
in the construction of the mycolic acid coat (Kalscheuer et al.,
2010).
Similar to the mycolate-containing lipids, the biosynthesis of
most lipid pathogenicity factors of the mycobacterial envelope
depends upon the intervention of PKSs (Daffe´ et al., 2014; Jack-
son et al., 2007). For such molecules, data clearly outline an
archetypal building and translocation pattern where fatty acyl
chains are synthesized by specific PKSs, then transferred onto
a polyol core, most often trehalose or substituted trehalose,
and after potential extra modifications, the product is ultimately
exported toward the envelope by a mycobacterial membrane1666 Chemistry & Biology 21, 1660–1669, December 18, 2014 ª2014protein large (MmpL)-type transmembrane protein. This scheme
is found for sulfolipid-1, polyacyl trehaloses, and lipooligosac-
charides, whose fatty acyl chains are carried by a trehalose
core, as well as for phenolic glycolipids and phthiocerol dimyco-
cerosates, whose fatty acyl chains are carried by a phthiocerol
core (Daffe´ et al., 2014). The present work combined with previ-
ous data highlight the conservation of this pattern for the myco-
late-containing lipids (Figure 6). However, our data emphasize a
fundamental discrepancy with the complex lipids cited above.
For the latter, the PKS proteins involved do not contain any TE
domain (Jackson et al., 2007) and the transacylation step is oper-
ated by discrete specific polyketide-associated protein (Pap)-
type acyltransferases (Bhatt et al., 2007; Chavadi et al., 2012;
Hatzios et al., 2009; Kumar et al., 2007; Onwueme et al., 2004;
Rombouts et al., 2011). In contrast, there is no Pap-encoding
gene in the vicinity of pks13 gene on the chromosome (Cole
et al., 1998). Instead, Pks13 is equipped with a TE domain struc-
turally distinct from Pap enzymes, which is responsible for the
transfer of the neosynthesized acyl chains onto the trehalose
core, as discussed above. This unique mechanism of transfer
of PKS products in mycobacteria appears as an extension of
the macrocyclisation mechanism, catalyzed by many TE do-
mains, where one nucleophilic atom of the polyketide plays the
role of acceptor for the intramolecular transfer of the polyketide
carbonyl extremity linked to the catalytic Ser (Frueh et al., 2008).
In the case of TEPks13, the main difference resides in the fact that
the transesterification is intermolecular and not intramolecular,
and therefore the domain must adapt an acceptor molecule in
its active site, close to the catalytic Ser (Figure S7). Accordingly,
the presence of a hydrophilic pocket that might accommodate
trehalose in the TEPks13 domain active site, at an adequate dis-
tance for a transacylation reaction, was predicted by molecular
modeling. Interestingly, an analogous intermolecular acyltrans-
ferase function has been recently reported for the PKS ArmB
of the tree pathogen fungus Armillaria mellea. ArmB transfers
its polyketide products onto a tricyclic sesquiterpene alcohol,
generating a cytotoxic melleolide (Lackner et al., 2013), but theElsevier Ltd All rights reserved
Figure 6. Proposed Schematic of the Last
Steps of Mycolic Acid Biosynthesis and
Transfer onto the Cell Wall in Mycobacteria
After loading onto Pks13, the acyl chains of car-
boxy-acyl-CoA and the meromycoloyl-AMP syn-
thesized by FAAL32 are condensed by the enzyme
resulting in an a-alkyl b-ketoacyl product linked
through a thioester bond to the C-terminal ACP
domain. The TE domain of Pks13 cleaves this
bond and most likely forms a transient covalent
ester bond between the a-alkyl b-ketoacyl chain
and the catalytic Ser1533 in its active site. Then,
the TEPks13 domain transfers the condensation
product onto trehalose to synthesize TMMk. This
precursor is then reduced by CmrA into TMM. The
latter is exported by MmpL3 membrane trans-
porter, probably into the mycomembrane (MM), where it is used by the mycoloyltransferases (Ag85 complex) tightly associated to the mycomembrane to
synthesize biologically active mycolate-containing compounds, i.e., the mAGP complex, the TDM, the GMM, and possibly the GroMM, which constitute major
components of the mycomembrane. The released free trehalose is recycled by the LpqY-SugA-SugB-SugC ABC transporter. The scheme is inspired by the
present study and previous works quoted in the text. CM, cytoplasmic membrane; GL, granular layer; PP, periplasm; PG, peptidoglycan; AG, arabinogalactan;
MM, mycomembrane; *, keto function.
See also Figure S1.
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strated yet.
The mycolic acid biosynthesis is the target of the TB drugs
isoniazid, ethionamide, and thiacetazone. Furthermore, most of
the newly discovered molecules showing promise for the treat-
ment of TB, notably multidrug-resistant TB, inhibit aspects of
M. tuberculosis cell envelope biogenesis, including the myco-
late-containing compound metabolism (Jackson et al., 2013).
In particular, target-based screenings focusing on this path-
way were successful (North et al., 2014). Given its unique fea-
tures, the TEPks13 domain constitutes an attractive target for
drug development. The recent discovery of a benzofuran
molecule both targeting the TEPks13 domain and inhibiting
M. tuberculosis growth validates this domain as a vulnerable
and druggable target (Ioerger et al., 2013). The activity assays
with the isolated TE domain and the entire Pks13 enzyme de-
signed during the present work constitute precious tools that
we are currently using for the screening of putative anti-TB
molecules.SIGNIFICANCE
The envelope of the tubercle bacillus contains critical path-
ogenicity factors made of exotic very long chain fatty acids
carried by a polyol core. So far, the archetypal building
pattern of these complex lipids corresponded to the biosyn-
thesis of the fatty acyl chains by specific polyketide syn-
thases, followed by their transfer onto the polyol moiety
catalyzed by a discrete Pap-type acyltransferase. In the spe-
cific case of the mycolate-containing compounds, we have
previously shown that Pks13 polyketide synthase catalyzes
the condensation reaction that produces a-alkyl b-ketoacyl
chains, direct precursors of the mycolates (Gavalda et al.,
2009). However, the enzymes/domains responsible for the
release of the condensation products from Pks13 and for
their transfer onto a polyol core remain unknown, leaving
gaps in the knowledge of the mycolate-containing com-
pound biosynthesis pathway. In contrast to the currentChemistry & Biology 21, 1660–166biosynthesismodel suggesting the involvement of a discrete
mycoloyl transferase, the present work shows that Pks13
catalyzes itself the cleavage of the thioester bond between
the enzyme and the neosynthesized acyl chains. We demon-
strate that this function is carried by its thioesterase-like
(TEPks13) domain. Most importantly, the latter exhibits an
acyltransferase function and directly transfers the mycolate
precursors onto a specific polyol acceptor molecule, treha-
lose, ultimately leading to the formation of trehalose mono-
mycolate, a common precursor of the mycolate-containing
compounds. Thus, the lipid transfer mechanism involved
does not use the conventional Pap-type acyltransferases,
in conflict with the archetypal biosynthesis pattern of the
mycobacterial complex lipids. Whole-cell screening on
M. tuberculosis has recently shown that the unique TE
domain of Pks13 represents a vulnerable and attractive
target for drug development to cure tuberculosis (Ioerger
et al., 2013).
EXPERIMENTAL PROCEDURES
Protein Production and Purification
See Supplemental Experimental Procedures.
Enzymatic Assays
Condensation assays contained 40 mM [1-14C]C14 acid (specific activity: 54
mCi/mmol, American Radiolabeled Chemicals) and 40 mM carboxy-C16-CoA
(synthesized and purified as described previously [Gavalda et al., 2009]),
8mMMgCl2, and 2mMATP, in 50mMHEPES (pH 7.2). The reactions (total vol-
ume: 10 ml) were started by the addition of 1–2 mM FAAL32 and 2 mM Pks13,
incubated for 6 hr at 30C, then stopped at –20C.Control experimentswithout
certain reagents or using heat-inactivated Pks13 (heated 10 min at 95C) were
performed, as mentioned in the text or figure legends. For MS analyses,
condensation assays were run in the same conditions with cold substrates,
in 100 ml final volume. The effect of putative acceptor molecules was evaluated
byadding themat various concentrations, asmentioned in the text or figure leg-
ends, in the presence of enzymes from glycerol-free stocks. In vitro comple-
mentation assays were performed in the presence of 200 mM trehalose and
500 mM glycerol, 1 mM FAAL32, and 1 mM of either WT Pks13 or Pks13
S1533A, ±4 or 8 mMof purified TEPks13 domain. The reactionmedia were either
kept intact or submitted to the following treatment: samples were mixed with9, December 18, 2014 ª2014 Elsevier Ltd All rights reserved 1667
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The Acyltransferase Function of Pks13’s TE Domain100 ml tetrahydrofuran and reduced for 1 hr by adding 500 ml NaBH4 0.5 M in
ethanol 99%; reactionswere stoppedby addition of 1ml acetic acid; for sapon-
ification, 1.5mlKOH10%(w/v) inCH3OH:toluene, 8:2were addedandsamples
incubated for 1 hr at 80C; the media were then acidified with 2 ml H2SO4; and
lipids were extracted with diethylether, washed with water, dried, and methyl-
ated with diazomethane (Figure 5C). Thioesterase and acyltransferase activity
assays were performed with either 40 mM [1-14C]C16-CoA (specific activity: 60
mCi/mmol, Perkin Elmer) or cold C16-CoA (for MS analysis), 100 mM (for
TEPks13 assays) or variable concentrations (for Pks13; specified in Figure 4) of
putative acceptor, and either 2 mM Pks13 or 4 mM TEPks13 domain, in 50 mM
HEPES (pH 7.2), incubated for 6 hr at 30C, then frozen at –20C. For all assays,
the solvent coming from the substrate solutions was evaporated before addi-
tion of the other reagents. All assays were performed at least in three indepen-
dent experiments. Kmwere measured in the presence of TEPks13 (2 mM), a fixed
concentration of [1-14C]C16-CoA (40 mM), and variable concentrations of treha-
lose (0.01–200mM) or glucose (0.5–1000mM; higher concentrations could not
be used because of problems of solubility and migration on thin layer). The
experimental conditionswere selected in order to be in a linear response range.
Data were fitted to theMichaelis-Menten equation by least-squares fits to a hy-
perbola using the program GraphPad Prism version 5.04.
TLC Analyses
See also Supplemental Experimental Procedures. Intact media of condensa-
tion assays and thioesterase/transacylase activity assays were analyzed by
TLC on silica gel G60 plates developed with CHCl3/CH3OH/H2O 65/25/4
and butan-1-ol/acetic acid/water 80/25/40, respectively. The lipid extracts
from reaction media or purified compounds submitted to chemical treatment
were spotted on TLC plates as diethylether solutions and developed with di-
chloromethane. The radiolabeling was detected by phosphorimaging (Variable
Mode Imager Typhoon TRIO, Amersham Biosciences) and quantified in arbi-
trary units using the ImageQuant version 5.1 software (Molecular Dynamics).
MALDI-TOF MS and MS/MS
See Supplemental Experimental Procedures.
Homology Modeling, Structural Comparison, and Visualization
See details in Supplemental Experimental Procedures. The SWISS-MODEL
program (www.swissmodel.expasy.org) (Arnold et al., 2006) was used to
generate a homology model from the sequence of the TEPks13 domain. Struc-
ture visualization and analyses were carried out using the PyMOL program
(www.pymol.org).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and one table and can be found with this article online at
http://dx.doi.org/10.1016/j.chembiol.2014.10.011.
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